221 related articles for article (PubMed ID: 23536766)
1. Pharmacometabolomics reveals racial differences in response to atenolol treatment.
Wikoff WR; Frye RF; Zhu H; Gong Y; Boyle S; Churchill E; Cooper-Dehoff RM; Beitelshees AL; Chapman AB; Fiehn O; Johnson JA; Kaddurah-Daouk R;
PLoS One; 2013; 8(3):e57639. PubMed ID: 23536766
[TBL] [Abstract][Full Text] [Related]
2. Atenolol induced HDL-C change in the pharmacogenomic evaluation of antihypertensive responses (PEAR) study.
McDonough CW; Gillis NK; Alsultan A; Chang SW; Kawaguchi-Suzuki M; Lang JE; Shahin MH; Buford TW; El Rouby NM; Sá AC; Langaee TY; Gums JG; Chapman AB; Cooper-DeHoff RM; Turner ST; Gong Y; Johnson JA
PLoS One; 2013; 8(10):e76984. PubMed ID: 24116192
[TBL] [Abstract][Full Text] [Related]
3. Gene Variants at Loci Related to Blood Pressure Account for Variation in Response to Antihypertensive Drugs Between Black and White Individuals.
Iniesta R; Campbell D; Venturini C; Faconti L; Singh S; Irvin MR; Cooper-DeHoff RM; Johnson JA; Turner ST; Arnett DK; Weale ME; Warren H; Munroe PB; Cruickshank K; Padmanabhan S; Lewis C; Chowienczyk P
Hypertension; 2019 Sep; 74(3):614-622. PubMed ID: 31327267
[TBL] [Abstract][Full Text] [Related]
4. Genome-Wide Association Approach Identified Novel Genetic Predictors of Heart Rate Response to β-Blockers.
Shahin MH; Conrado DJ; Gonzalez D; Gong Y; Lobmeyer MT; Beitelshees AL; Boerwinkle E; Gums JG; Chapman A; Turner ST; Cooper-DeHoff RM; Johnson JA
J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478026
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Blood Pressure Control Rates Among Recommended Drug Selection Strategies for Initial Therapy of Hypertension.
Gharaibeh KA; Turner ST; Hamadah AM; Chapman AB; Cooper-Dehoff RM; Johnson JA; Gums JG; Bailey KR; Schwartz GL
Am J Hypertens; 2016 Oct; 29(10):1186-94. PubMed ID: 27365079
[TBL] [Abstract][Full Text] [Related]
6. Hydrochlorothiazide-induced hyperuricaemia in the pharmacogenomic evaluation of antihypertensive responses study.
Vandell AG; McDonough CW; Gong Y; Langaee TY; Lucas AM; Chapman AB; Gums JG; Beitelshees AL; Bailey KR; Johnson RJ; Boerwinkle E; Turner ST; Cooper-DeHoff RM; Johnson JA
J Intern Med; 2014 Nov; 276(5):486-97. PubMed ID: 24612202
[TBL] [Abstract][Full Text] [Related]
7. Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study.
Gong Y; McDonough CW; Wang Z; Hou W; Cooper-DeHoff RM; Langaee TY; Beitelshees AL; Chapman AB; Gums JG; Bailey KR; Boerwinkle E; Turner ST; Johnson JA
Circ Cardiovasc Genet; 2012 Dec; 5(6):686-91. PubMed ID: 23087401
[TBL] [Abstract][Full Text] [Related]
8. PTPRD gene associated with blood pressure response to atenolol and resistant hypertension.
Gong Y; McDonough CW; Beitelshees AL; El Rouby N; Hiltunen TP; O'Connell JR; Padmanabhan S; Langaee TY; Hall K; Schmidt SO; Curry RW; Gums JG; Donner KM; Kontula KK; Bailey KR; Boerwinkle E; Takahashi A; Tanaka T; Kubo M; Chapman AB; Turner ST; Pepine CJ; Cooper-DeHoff RM; Johnson JA
J Hypertens; 2015 Nov; 33(11):2278-85. PubMed ID: 26425837
[TBL] [Abstract][Full Text] [Related]
9. G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.
Vandell AG; Lobmeyer MT; Gawronski BE; Langaee TY; Gong Y; Gums JG; Beitelshees AL; Turner ST; Chapman AB; Cooper-DeHoff RM; Bailey KR; Boerwinkle E; Pepine CJ; Liggett SB; Johnson JA
Hypertension; 2012 Oct; 60(4):957-64. PubMed ID: 22949529
[TBL] [Abstract][Full Text] [Related]
10. Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression.
Duarte JD; Turner ST; Tran B; Chapman AB; Bailey KR; Gong Y; Gums JG; Langaee TY; Beitelshees AL; Cooper-Dehoff RM; Boerwinkle E; Johnson JA
Pharmacogenomics J; 2013 Jun; 13(3):257-63. PubMed ID: 22350108
[TBL] [Abstract][Full Text] [Related]
11. PROX1 gene variant is associated with fasting glucose change after antihypertensive treatment.
Gong Y; McDonough CW; Beitelshees AL; Karnes JH; O'Connell JR; Turner ST; Chapman AB; Gums JG; Bailey KR; Boerwinkle E; Johnson JA; Cooper-DeHoff RM
Pharmacotherapy; 2014 Feb; 34(2):123-30. PubMed ID: 24122840
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomic Genome-Wide Meta-Analysis of Blood Pressure Response to β-Blockers in Hypertensive African Americans.
Gong Y; Wang Z; Beitelshees AL; McDonough CW; Langaee TY; Hall K; Schmidt SO; Curry RW; Gums JG; Bailey KR; Boerwinkle E; Chapman AB; Turner ST; Cooper-DeHoff RM; Johnson JA
Hypertension; 2016 Mar; 67(3):556-63. PubMed ID: 26729753
[TBL] [Abstract][Full Text] [Related]
13. Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
Ademuyiwa FO; Tao Y; Luo J; Weilbaecher K; Ma CX
Breast Cancer Res Treat; 2017 Feb; 161(3):491-499. PubMed ID: 27915434
[TBL] [Abstract][Full Text] [Related]
14. Racial differences in circulating natriuretic peptide levels: the atherosclerosis risk in communities study.
Gupta DK; Claggett B; Wells Q; Cheng S; Li M; Maruthur N; Selvin E; Coresh J; Konety S; Butler KR; Mosley T; Boerwinkle E; Hoogeveen R; Ballantyne CM; Solomon SD
J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25999400
[TBL] [Abstract][Full Text] [Related]
15. Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis.
Hughes LB; Beasley TM; Patel H; Tiwari HK; Morgan SL; Baggott JE; Saag KG; McNicholl J; Moreland LW; Alarcón GS; Bridges SL
Ann Rheum Dis; 2006 Sep; 65(9):1213-8. PubMed ID: 16439441
[TBL] [Abstract][Full Text] [Related]
16. Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Cushman WC; Reda DJ; Perry HM; Williams D; Abdellatif M; Materson BJ
Arch Intern Med; 2000 Mar; 160(6):825-31. PubMed ID: 10737282
[TBL] [Abstract][Full Text] [Related]
17. Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment. Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial.
Kurland L; Liljedahl U; Karlsson J; Kahan T; Malmqvist K; Melhus H; Syvänen AC; Lind L
Am J Hypertens; 2004 Jan; 17(1):8-13. PubMed ID: 14700505
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of chronic oral antihypertensive therapies on systemic arterial circulation and ventricular energetics in African-American patients.
Cholley BP; Shroff SG; Sandelski J; Korcarz C; Balasia BA; Jain S; Berger DS; Murphy MB; Marcus RH; Lang RM
Circulation; 1995 Feb; 91(4):1052-62. PubMed ID: 7850941
[TBL] [Abstract][Full Text] [Related]
19. A Genetic Response Score for Hydrochlorothiazide Use: Insights From Genomics and Metabolomics Integration.
Shahin MH; Gong Y; McDonough CW; Rotroff DM; Beitelshees AL; Garrett TJ; Gums JG; Motsinger-Reif A; Chapman AB; Turner ST; Boerwinkle E; Frye RF; Fiehn O; Cooper-DeHoff RM; Kaddurah-Daouk R; Johnson JA
Hypertension; 2016 Sep; 68(3):621-9. PubMed ID: 27381900
[TBL] [Abstract][Full Text] [Related]
20. Sequence variation of bradykinin receptors B1 and B2 and association with hypertension.
Cui J; Melista E; Chazaro I; Zhang Y; Zhou X; Manolis AJ; Baldwin CT; Destefano AL; Gavras H
J Hypertens; 2005 Jan; 23(1):55-62. PubMed ID: 15643125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
